

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.91677447 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.91677447 |
| 3 | fatty acid elongation (GO:0030497) | 6.88560553 |
| 4 | ensheathment of neurons (GO:0007272) | 5.87609427 |
| 5 | axon ensheathment (GO:0008366) | 5.87609427 |
| 6 | myelination (GO:0042552) | 5.83164690 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.67087328 |
| 8 | cholesterol biosynthetic process (GO:0006695) | 4.59958886 |
| 9 | myelin maintenance (GO:0043217) | 4.50100462 |
| 10 | adhesion of symbiont to host cell (GO:0044650) | 4.43928091 |
| 11 | virion attachment to host cell (GO:0019062) | 4.43928091 |
| 12 | creatine metabolic process (GO:0006600) | 4.18680997 |
| 13 | response to peptidoglycan (GO:0032494) | 4.18325139 |
| 14 | sterol biosynthetic process (GO:0016126) | 4.12809646 |
| 15 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.08821389 |
| 16 | negative regulation of protein localization to cell surface (GO:2000009) | 4.04279018 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.01327645 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.01327645 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.01327645 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.01327645 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.01327645 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.01327645 |
| 23 | amyloid precursor protein metabolic process (GO:0042982) | 4.00888772 |
| 24 | oligodendrocyte differentiation (GO:0048709) | 3.76667249 |
| 25 | protein localization to endosome (GO:0036010) | 3.73406224 |
| 26 | regulation of collateral sprouting (GO:0048670) | 3.69183402 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.64471176 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.60477872 |
| 29 | negative regulation of neurotransmitter transport (GO:0051589) | 3.56538063 |
| 30 | response to lipoprotein particle (GO:0055094) | 3.56158726 |
| 31 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.53629552 |
| 32 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.52713659 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.50281657 |
| 34 | amyloid precursor protein catabolic process (GO:0042987) | 3.49094054 |
| 35 | astrocyte development (GO:0014002) | 3.48660342 |
| 36 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.46491999 |
| 37 | establishment of mitochondrion localization (GO:0051654) | 3.44959111 |
| 38 | adhesion of symbiont to host (GO:0044406) | 3.44003394 |
| 39 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.42945797 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.41683491 |
| 41 | isoprenoid biosynthetic process (GO:0008299) | 3.39156907 |
| 42 | glycerophospholipid catabolic process (GO:0046475) | 3.38836604 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.38610891 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.37615371 |
| 45 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.36248629 |
| 46 | substantia nigra development (GO:0021762) | 3.36071267 |
| 47 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.29556839 |
| 48 | import into cell (GO:0098657) | 3.28365486 |
| 49 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.26566833 |
| 50 | barbed-end actin filament capping (GO:0051016) | 3.26068649 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.19595625 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.19080018 |
| 53 | low-density lipoprotein particle clearance (GO:0034383) | 3.19067328 |
| 54 | response to redox state (GO:0051775) | 3.16935588 |
| 55 | fibril organization (GO:0097435) | 3.15561989 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.15026507 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.15026507 |
| 58 | regulation of lipoprotein metabolic process (GO:0050746) | 3.12246955 |
| 59 | photoreceptor cell differentiation (GO:0046530) | 3.11681615 |
| 60 | eye photoreceptor cell differentiation (GO:0001754) | 3.11681615 |
| 61 | L-amino acid import (GO:0043092) | 3.11623376 |
| 62 | response to type I interferon (GO:0034340) | 3.11005685 |
| 63 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.10514363 |
| 64 | skin morphogenesis (GO:0043589) | 3.10473685 |
| 65 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.10125786 |
| 66 | membrane tubulation (GO:0097320) | 3.05277030 |
| 67 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.05114433 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04619220 |
| 69 | negative regulation of cell killing (GO:0031342) | 3.04619220 |
| 70 | apical protein localization (GO:0045176) | 3.04138489 |
| 71 | membrane raft organization (GO:0031579) | 3.04036836 |
| 72 | type B pancreatic cell proliferation (GO:0044342) | 3.03610372 |
| 73 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03044819 |
| 74 | stress fiber assembly (GO:0043149) | 2.98267455 |
| 75 | positive regulation of actin filament depolymerization (GO:0030836) | 2.96061834 |
| 76 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94389101 |
| 77 | asymmetric protein localization (GO:0008105) | 2.94284253 |
| 78 | extracellular fibril organization (GO:0043206) | 2.93961867 |
| 79 | protein neddylation (GO:0045116) | 2.92573722 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.90727854 |
| 81 | detection of other organism (GO:0098543) | 2.90418732 |
| 82 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.90371660 |
| 83 | substrate-dependent cell migration (GO:0006929) | 2.89807879 |
| 84 | glycosylceramide metabolic process (GO:0006677) | 2.88144891 |
| 85 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.87907631 |
| 86 | detection of external biotic stimulus (GO:0098581) | 2.87792615 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.84698154 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 2.84024551 |
| 89 | peripheral nervous system axon ensheathment (GO:0032292) | 2.77471594 |
| 90 | myelination in peripheral nervous system (GO:0022011) | 2.77471594 |
| 91 | response to methylmercury (GO:0051597) | 2.75966657 |
| 92 | regulation of vitamin metabolic process (GO:0030656) | 2.75894320 |
| 93 | positive regulation of interleukin-17 production (GO:0032740) | 2.75549458 |
| 94 | response to interferon-alpha (GO:0035455) | 2.75461556 |
| 95 | positive regulation of glial cell differentiation (GO:0045687) | 2.75395457 |
| 96 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.75211651 |
| 97 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.74693222 |
| 98 | nucleotide transmembrane transport (GO:1901679) | 2.72492071 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72439510 |
| 100 | germinal center formation (GO:0002467) | 2.70200541 |
| 101 | axon development (GO:0061564) | 2.68821237 |
| 102 | granulocyte activation (GO:0036230) | 2.68726490 |
| 103 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68530478 |
| 104 | response to host (GO:0075136) | 2.68114546 |
| 105 | response to host defenses (GO:0052200) | 2.68114546 |
| 106 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68114546 |
| 107 | neuron remodeling (GO:0016322) | 2.66492345 |
| 108 | cell adhesion mediated by integrin (GO:0033627) | 2.62998429 |
| 109 | presynaptic membrane organization (GO:0097090) | 2.62108011 |
| 110 | negative regulation of JUN kinase activity (GO:0043508) | 2.61525029 |
| 111 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.61386602 |
| 112 | pinocytosis (GO:0006907) | 2.60706815 |
| 113 | peripheral nervous system development (GO:0007422) | 2.60032910 |
| 114 | protein palmitoylation (GO:0018345) | 2.58875868 |
| 115 | neutrophil activation (GO:0042119) | 2.58349875 |
| 116 | negative regulation of acute inflammatory response (GO:0002674) | 2.57180450 |
| 117 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.57113877 |
| 118 | GPI anchor biosynthetic process (GO:0006506) | 2.56814142 |
| 119 | detection of bacterium (GO:0016045) | 2.55363993 |
| 120 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.54864653 |
| 121 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.53392527 |
| 122 | response to progesterone (GO:0032570) | 2.52641007 |
| 123 | response to host immune response (GO:0052572) | 2.51755831 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.51755831 |
| 125 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.50968048 |
| 126 | positive regulation of gliogenesis (GO:0014015) | 2.50327250 |
| 127 | peptidyl-cysteine modification (GO:0018198) | 2.50220197 |
| 128 | intracellular pH reduction (GO:0051452) | 2.49525540 |
| 129 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.49261267 |
| 130 | positive regulation of action potential (GO:0045760) | 2.49202793 |
| 131 | regulation of chemokine biosynthetic process (GO:0045073) | 2.48660326 |
| 132 | tissue regeneration (GO:0042246) | 2.48418386 |
| 133 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.48220331 |
| 134 | magnesium ion transport (GO:0015693) | 2.47224616 |
| 135 | very long-chain fatty acid metabolic process (GO:0000038) | 2.46901789 |
| 136 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.46389205 |
| 137 | regulation of necroptotic process (GO:0060544) | 2.46372420 |
| 138 | regulation of podosome assembly (GO:0071801) | 2.45830181 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.45177294 |
| 140 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.45106944 |
| 141 | modulation by symbiont of host cellular process (GO:0044068) | 2.45008342 |
| 142 | leukocyte aggregation (GO:0070486) | 2.44388745 |
| 143 | response to laminar fluid shear stress (GO:0034616) | 2.44379935 |
| 144 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.43761694 |
| 145 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.42835171 |
| 146 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.42830790 |
| 147 | cellular response to virus (GO:0098586) | 2.42595632 |
| 148 | cellular response to epinephrine stimulus (GO:0071872) | 2.41592879 |
| 149 | chronic inflammatory response (GO:0002544) | 2.41549043 |
| 150 | membrane assembly (GO:0071709) | 2.41526427 |
| 151 | regulation of interferon-alpha production (GO:0032647) | 2.40951496 |
| 152 | GPI anchor metabolic process (GO:0006505) | 2.40739328 |
| 153 | protein heterotrimerization (GO:0070208) | 2.39640320 |
| 154 | detection of biotic stimulus (GO:0009595) | 2.39399575 |
| 155 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.39172344 |
| 156 | response to muramyl dipeptide (GO:0032495) | 2.38617347 |
| 157 | interferon-gamma secretion (GO:0072643) | 2.37909874 |
| 158 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.37609435 |
| 159 | negative regulation of viral entry into host cell (GO:0046597) | 2.37526088 |
| 160 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.37433125 |
| 161 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.37318905 |
| 162 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.36801807 |
| 163 | positive regulation of receptor recycling (GO:0001921) | 2.36499008 |
| 164 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.35592116 |
| 165 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.35508181 |
| 166 | thioester biosynthetic process (GO:0035384) | 2.35351999 |
| 167 | acyl-CoA biosynthetic process (GO:0071616) | 2.35351999 |
| 168 | regulation of interleukin-6 production (GO:0032675) | 2.35085492 |
| 169 | hyaluronan catabolic process (GO:0030214) | 2.34756779 |
| 170 | negative regulation of interleukin-6 production (GO:0032715) | 2.34732054 |
| 171 | glial cell development (GO:0021782) | 2.34186888 |
| 172 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.34125521 |
| 173 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.33709622 |
| 174 | cell migration involved in heart development (GO:0060973) | 2.33603232 |
| 175 | nerve growth factor signaling pathway (GO:0038180) | 2.33412741 |
| 176 | regulation of necrotic cell death (GO:0010939) | 2.33192699 |
| 177 | positive regulation of interleukin-6 production (GO:0032755) | 2.33189970 |
| 178 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.33083009 |
| 179 | regulation of type 2 immune response (GO:0002828) | 2.33065726 |
| 180 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.32989730 |
| 181 | pH reduction (GO:0045851) | 2.32805449 |
| 182 | membrane protein ectodomain proteolysis (GO:0006509) | 2.32084888 |
| 183 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.31698576 |
| 184 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.31698576 |
| 185 | negative regulation of axonogenesis (GO:0050771) | 2.30673713 |
| 186 | enteric nervous system development (GO:0048484) | 2.30271880 |
| 187 | amino acid import (GO:0043090) | 2.30256354 |
| 188 | positive regulation of interferon-alpha production (GO:0032727) | 2.29782649 |
| 189 | hypotonic response (GO:0006971) | 2.29038256 |
| 190 | regulation of interleukin-17 production (GO:0032660) | 2.29000908 |
| 191 | positive regulation of type 2 immune response (GO:0002830) | 2.28962598 |
| 192 | macrophage activation (GO:0042116) | 2.28900168 |
| 193 | response to nerve growth factor (GO:1990089) | 2.27520245 |
| 194 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.27520245 |
| 195 | presynaptic membrane assembly (GO:0097105) | 2.26936456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.67823362 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.22154157 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97035161 |
| 4 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.92332094 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.63179106 |
| 6 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.45002501 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.43048064 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.40289317 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40154907 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.34570123 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.29896408 |
| 12 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.29166084 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22949050 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.22195587 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20213791 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.15269192 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.06049569 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.04223771 |
| 19 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00742577 |
| 20 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.97463768 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95606559 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.93322924 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92840475 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91029215 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90936808 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.84523784 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79689679 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79178168 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.78643094 |
| 30 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.78643094 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.74497546 |
| 32 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.74256583 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69878577 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68549625 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67329420 |
| 36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66227365 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65830391 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65143604 |
| 39 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64065516 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62885765 |
| 41 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.59090097 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58068833 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58039629 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54612962 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.54429956 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54339391 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54300287 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53858176 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.52566484 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51670413 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51471930 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51471930 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.51011594 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50956869 |
| 55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.50859002 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50353267 |
| 57 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.49667862 |
| 58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.49200355 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49065047 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47303930 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46444941 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46160639 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45474326 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45070288 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44989448 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44480698 |
| 67 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.44304748 |
| 68 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40667862 |
| 69 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39626453 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38820650 |
| 71 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.38124089 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34402326 |
| 73 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.33738033 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33441755 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33026528 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32309502 |
| 77 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.32233472 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30292629 |
| 79 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29479351 |
| 80 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29334137 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.28891622 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.28891622 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28545500 |
| 84 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.28534599 |
| 85 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.28422394 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27155274 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25424284 |
| 88 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.24379505 |
| 89 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23825597 |
| 90 | MYC_22102868_ChIP-Seq_BL_Human | 1.23162242 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.22640663 |
| 92 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21970623 |
| 93 | * MAF_26560356_Chip-Seq_TH2_Human | 1.21344609 |
| 94 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20212317 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20143754 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19505006 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19434616 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18350658 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17547724 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17411926 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17010106 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15509508 |
| 103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15228447 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15142104 |
| 105 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14569418 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13774428 |
| 107 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13397694 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13170645 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13026019 |
| 110 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12969007 |
| 111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12685590 |
| 112 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.12305564 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11727802 |
| 114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11711842 |
| 115 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10962177 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.10363199 |
| 117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09808747 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09654600 |
| 119 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09359575 |
| 120 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09347997 |
| 121 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08716183 |
| 122 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.08705997 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08418685 |
| 124 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08210126 |
| 125 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07736314 |
| 126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06899914 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06729885 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06615890 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06512878 |
| 130 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06325513 |
| 131 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06257642 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06028995 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05931347 |
| 134 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04532466 |
| 135 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04046198 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03877999 |
| 137 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.03830726 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03678802 |
| 139 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03142629 |
| 140 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03131957 |
| 141 | P68_20966046_ChIP-Seq_HELA_Human | 1.01931634 |
| 142 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00902795 |
| 143 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.00754153 |
| 144 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00494031 |
| 145 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00174444 |
| 146 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99300581 |
| 147 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98629966 |
| 148 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.98225955 |
| 149 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97239574 |
| 150 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97223922 |
| 151 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94147524 |
| 152 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92963263 |
| 153 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91435140 |
| 154 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91430953 |
| 155 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90427209 |
| 156 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89638016 |
| 157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89554290 |
| 158 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89458176 |
| 159 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86811807 |
| 160 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86526580 |
| 161 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85229743 |
| 162 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84947705 |
| 163 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84932195 |
| 164 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84341786 |
| 165 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83926649 |
| 166 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.83871923 |
| 167 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.82337838 |
| 168 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.82098507 |
| 169 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81594666 |
| 170 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80683412 |
| 171 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.78750726 |
| 172 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.78641779 |
| 173 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78038713 |
| 174 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77576726 |
| 175 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76989670 |
| 176 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76370729 |
| 177 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.75376925 |
| 178 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.75191376 |
| 179 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74953015 |
| 180 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.73643250 |
| 181 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.73269028 |
| 182 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.71970480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.60456357 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.70382832 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.48981555 |
| 4 | MP0003690_abnormal_glial_cell | 3.40411787 |
| 5 | MP0005451_abnormal_body_composition | 2.93753895 |
| 6 | MP0003880_abnormal_central_pattern | 2.86339980 |
| 7 | MP0003329_amyloid_beta_deposits | 2.75219796 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.69304242 |
| 9 | MP0005171_absent_coat_pigmentation | 2.67220268 |
| 10 | MP0004270_analgesia | 2.66482110 |
| 11 | MP0006082_CNS_inflammation | 2.30420555 |
| 12 | MP0006054_spinal_hemorrhage | 2.30162535 |
| 13 | MP0003634_abnormal_glial_cell | 2.28885268 |
| 14 | MP0003136_yellow_coat_color | 2.23337486 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.18799690 |
| 16 | MP0001542_abnormal_bone_strength | 2.17585394 |
| 17 | MP0003279_aneurysm | 2.15635740 |
| 18 | MP0000604_amyloidosis | 2.15610474 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 2.13634836 |
| 20 | MP0004742_abnormal_vestibular_system | 2.11182639 |
| 21 | MP0001905_abnormal_dopamine_level | 2.03951366 |
| 22 | MP0003724_increased_susceptibility_to | 2.03716924 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.96350239 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.90057231 |
| 25 | MP0001529_abnormal_vocalization | 1.88668406 |
| 26 | MP0005023_abnormal_wound_healing | 1.81131670 |
| 27 | MP0000858_altered_metastatic_potential | 1.79388694 |
| 28 | MP0008260_abnormal_autophagy | 1.73905511 |
| 29 | MP0004858_abnormal_nervous_system | 1.73624989 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.73004590 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.71277236 |
| 32 | MP0004510_myositis | 1.70531258 |
| 33 | MP0004947_skin_inflammation | 1.69777452 |
| 34 | MP0001485_abnormal_pinna_reflex | 1.69277654 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.68571635 |
| 36 | MP0002272_abnormal_nervous_system | 1.66889574 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.66572870 |
| 38 | MP0002295_abnormal_pulmonary_circulatio | 1.62836746 |
| 39 | MP0003632_abnormal_nervous_system | 1.62131759 |
| 40 | MP0003828_pulmonary_edema | 1.61156366 |
| 41 | MP0004142_abnormal_muscle_tone | 1.60611609 |
| 42 | MP0004885_abnormal_endolymph | 1.59610259 |
| 43 | MP0002254_reproductive_system_inflammat | 1.56516676 |
| 44 | MP0001346_abnormal_lacrimal_gland | 1.55821586 |
| 45 | MP0009840_abnormal_foam_cell | 1.55547971 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.50537991 |
| 47 | MP0001486_abnormal_startle_reflex | 1.49702512 |
| 48 | MP0005275_abnormal_skin_tensile | 1.47238147 |
| 49 | MP0009764_decreased_sensitivity_to | 1.46591172 |
| 50 | MP0005390_skeleton_phenotype | 1.46498310 |
| 51 | MP0009278_abnormal_bone_marrow | 1.45709151 |
| 52 | MP0003448_altered_tumor_morphology | 1.45018667 |
| 53 | MP0003075_altered_response_to | 1.44916124 |
| 54 | MP0000685_abnormal_immune_system | 1.41623779 |
| 55 | MP0000767_abnormal_smooth_muscle | 1.41363961 |
| 56 | MP0002229_neurodegeneration | 1.40544437 |
| 57 | MP0002064_seizures | 1.40288834 |
| 58 | MP0009785_altered_susceptibility_to | 1.38685922 |
| 59 | MP0005410_abnormal_fertilization | 1.38637589 |
| 60 | MP0000778_abnormal_nervous_system | 1.32851260 |
| 61 | MP0002419_abnormal_innate_immunity | 1.32409838 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.31904640 |
| 63 | MP0001851_eye_inflammation | 1.31571392 |
| 64 | MP0003195_calcinosis | 1.29784261 |
| 65 | MP0001849_ear_inflammation | 1.27949557 |
| 66 | MP0005409_darkened_coat_color | 1.27924685 |
| 67 | MP0005164_abnormal_response_to | 1.25882902 |
| 68 | MP0010368_abnormal_lymphatic_system | 1.25397048 |
| 69 | MP0008004_abnormal_stomach_pH | 1.23585771 |
| 70 | MP0002452_abnormal_antigen_presenting | 1.22989307 |
| 71 | MP0002060_abnormal_skin_morphology | 1.22449764 |
| 72 | MP0002723_abnormal_immune_serum | 1.22091472 |
| 73 | MP0004043_abnormal_pH_regulation | 1.20393898 |
| 74 | MP0000751_myopathy | 1.19679004 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 1.19145872 |
| 76 | MP0005408_hypopigmentation | 1.18702350 |
| 77 | MP0002132_abnormal_respiratory_system | 1.18388293 |
| 78 | MP0010678_abnormal_skin_adnexa | 1.17913214 |
| 79 | MP0000383_abnormal_hair_follicle | 1.17705570 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.17509798 |
| 81 | MP0003631_nervous_system_phenotype | 1.17218034 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.13475781 |
| 83 | MP0005503_abnormal_tendon_morphology | 1.12247484 |
| 84 | MP0005000_abnormal_immune_tolerance | 1.11523999 |
| 85 | MP0009046_muscle_twitch | 1.09206761 |
| 86 | MP0008469_abnormal_protein_level | 1.08748480 |
| 87 | MP0005166_decreased_susceptibility_to | 1.07984062 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.07914963 |
| 89 | MP0005464_abnormal_platelet_physiology | 1.06261929 |
| 90 | MP0002405_respiratory_system_inflammati | 1.05839437 |
| 91 | MP0005387_immune_system_phenotype | 1.04802853 |
| 92 | MP0001790_abnormal_immune_system | 1.04802853 |
| 93 | MP0001819_abnormal_immune_cell | 1.04720402 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 1.04640950 |
| 95 | MP0001243_abnormal_dermal_layer | 1.04269752 |
| 96 | MP0001348_abnormal_lacrimal_gland | 1.03890958 |
| 97 | MP0004272_abnormal_basement_membrane | 1.03547239 |
| 98 | MP0002420_abnormal_adaptive_immunity | 1.03509614 |
| 99 | MP0005595_abnormal_vascular_smooth | 1.01362149 |
| 100 | MP0001958_emphysema | 1.01291444 |
| 101 | MP0004134_abnormal_chest_morphology | 1.01183057 |
| 102 | MP0003303_peritoneal_inflammation | 1.00809175 |
| 103 | MP0001800_abnormal_humoral_immune | 1.00158764 |
| 104 | MP0004381_abnormal_hair_follicle | 0.99205188 |
| 105 | MP0000462_abnormal_digestive_system | 0.98479763 |
| 106 | MP0000343_altered_response_to | 0.98316658 |
| 107 | MP0003633_abnormal_nervous_system | 0.97615171 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.95680494 |
| 109 | MP0000249_abnormal_blood_vessel | 0.95016391 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.93793734 |
| 111 | MP0005025_abnormal_response_to | 0.92543178 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.91014614 |
| 113 | MP0002933_joint_inflammation | 0.90113727 |
| 114 | MP0001440_abnormal_grooming_behavior | 0.89600543 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.88139360 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.87936794 |
| 117 | MP0005076_abnormal_cell_differentiation | 0.87764311 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.87572515 |
| 119 | MP0004859_abnormal_synaptic_plasticity | 0.87391019 |
| 120 | MP0000749_muscle_degeneration | 0.87292736 |
| 121 | MP0002998_abnormal_bone_remodeling | 0.86719204 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.85784842 |
| 123 | MP0004233_abnormal_muscle_weight | 0.85175492 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.84972425 |
| 125 | MP0005388_respiratory_system_phenotype | 0.83962168 |
| 126 | MP0002133_abnormal_respiratory_system | 0.83962168 |
| 127 | MP0009745_abnormal_behavioral_response | 0.82890735 |
| 128 | MP0005508_abnormal_skeleton_morphology | 0.82521844 |
| 129 | MP0000747_muscle_weakness | 0.82329043 |
| 130 | MP0005083_abnormal_biliary_tract | 0.81135059 |
| 131 | MP0003186_abnormal_redox_activity | 0.79388788 |
| 132 | MP0003795_abnormal_bone_structure | 0.79277220 |
| 133 | MP0001853_heart_inflammation | 0.79063042 |
| 134 | MP0001970_abnormal_pain_threshold | 0.77770059 |
| 135 | MP0004147_increased_porphyrin_level | 0.77602263 |
| 136 | MP0000955_abnormal_spinal_cord | 0.76824535 |
| 137 | MP0005310_abnormal_salivary_gland | 0.76702007 |
| 138 | MP0002882_abnormal_neuron_morphology | 0.75696592 |
| 139 | MP0002066_abnormal_motor_capabilities/c | 0.75690862 |
| 140 | MP0002090_abnormal_vision | 0.75260476 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.74815583 |
| 142 | MP0005397_hematopoietic_system_phenotyp | 0.74566629 |
| 143 | MP0001545_abnormal_hematopoietic_system | 0.74566629 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.71875703 |
| 145 | MP0005375_adipose_tissue_phenotype | 0.71717430 |
| 146 | MP0004883_abnormal_blood_vessel | 0.69480789 |
| 147 | MP0003436_decreased_susceptibility_to | 0.68905934 |
| 148 | MP0000716_abnormal_immune_system | 0.66836519 |
| 149 | MP0005195_abnormal_posterior_eye | 0.65565606 |
| 150 | MP0001663_abnormal_digestive_system | 0.65325430 |
| 151 | MP0003091_abnormal_cell_migration | 0.64435573 |
| 152 | MP0000490_abnormal_crypts_of | 0.64142408 |
| 153 | MP0002896_abnormal_bone_mineralization | 0.64033438 |
| 154 | MP0000372_irregular_coat_pigmentation | 0.63987364 |
| 155 | MP0000647_abnormal_sebaceous_gland | 0.63570368 |
| 156 | MP0002752_abnormal_somatic_nervous | 0.61473261 |
| 157 | MP0002332_abnormal_exercise_endurance | 0.60696593 |
| 158 | MP0004924_abnormal_behavior | 0.60218508 |
| 159 | MP0005386_behavior/neurological_phenoty | 0.60218508 |
| 160 | MP0005165_increased_susceptibility_to | 0.59989403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.86401999 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.84826631 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.84826631 |
| 4 | Parakeratosis (HP:0001036) | 5.55626667 |
| 5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.49493278 |
| 6 | Protrusio acetabuli (HP:0003179) | 4.47318700 |
| 7 | Sensory axonal neuropathy (HP:0003390) | 4.30994511 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.27358653 |
| 9 | Peripheral hypomyelination (HP:0007182) | 4.20031593 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.05177578 |
| 11 | Onion bulb formation (HP:0003383) | 3.94614164 |
| 12 | Orchitis (HP:0100796) | 3.75433630 |
| 13 | Axonal loss (HP:0003447) | 3.66262798 |
| 14 | Myositis (HP:0100614) | 3.60049115 |
| 15 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.58269837 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.49637916 |
| 17 | Peritonitis (HP:0002586) | 3.48426080 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.47748703 |
| 19 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.35475424 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.31229079 |
| 21 | Abnormality of glycolysis (HP:0004366) | 3.31229079 |
| 22 | Cerebral hemorrhage (HP:0001342) | 3.28950376 |
| 23 | Aortic aneurysm (HP:0004942) | 3.27603009 |
| 24 | Cervical subluxation (HP:0003308) | 3.20204179 |
| 25 | Muscle fiber splitting (HP:0003555) | 3.13657968 |
| 26 | Vertebral compression fractures (HP:0002953) | 3.11020381 |
| 27 | Cerebral hypomyelination (HP:0006808) | 3.03867499 |
| 28 | Atrophic scars (HP:0001075) | 3.03506424 |
| 29 | Vascular tortuosity (HP:0004948) | 3.00204582 |
| 30 | Increased connective tissue (HP:0009025) | 2.96532564 |
| 31 | Slow saccadic eye movements (HP:0000514) | 2.88768192 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.87768801 |
| 33 | Optic neuritis (HP:0100653) | 2.87768801 |
| 34 | Abnormal auditory evoked potentials (HP:0006958) | 2.85424847 |
| 35 | Dilatation of the ascending aorta (HP:0005111) | 2.83973818 |
| 36 | Leukodystrophy (HP:0002415) | 2.80062946 |
| 37 | Hepatosplenomegaly (HP:0001433) | 2.79771242 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77761306 |
| 39 | Short nail (HP:0001799) | 2.73518783 |
| 40 | Akinesia (HP:0002304) | 2.72555994 |
| 41 | Stridor (HP:0010307) | 2.72198325 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.71873296 |
| 43 | Arterial tortuosity (HP:0005116) | 2.70789706 |
| 44 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.67537245 |
| 45 | Osteolytic defects of the hand bones (HP:0009699) | 2.67537245 |
| 46 | Aortic dissection (HP:0002647) | 2.64706511 |
| 47 | Termporal pattern (HP:0011008) | 2.64532570 |
| 48 | Insidious onset (HP:0003587) | 2.64532570 |
| 49 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.62661501 |
| 50 | Spastic gait (HP:0002064) | 2.62428312 |
| 51 | Blue sclerae (HP:0000592) | 2.60743716 |
| 52 | Spastic paraparesis (HP:0002313) | 2.58773522 |
| 53 | Dysmetria (HP:0001310) | 2.57342884 |
| 54 | Fragile skin (HP:0001030) | 2.57237026 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51040478 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51040478 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51040478 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.50753958 |
| 59 | Ankle contracture (HP:0006466) | 2.48131789 |
| 60 | Clumsiness (HP:0002312) | 2.46244577 |
| 61 | Intention tremor (HP:0002080) | 2.44858069 |
| 62 | Alacrima (HP:0000522) | 2.40500764 |
| 63 | Hyporeflexia of lower limbs (HP:0002600) | 2.38764388 |
| 64 | Spinal rigidity (HP:0003306) | 2.38682755 |
| 65 | Pheochromocytoma (HP:0002666) | 2.37354658 |
| 66 | Stomatitis (HP:0010280) | 2.35573919 |
| 67 | Thin bony cortex (HP:0002753) | 2.33204591 |
| 68 | Hypoplasia of the iris (HP:0007676) | 2.33046544 |
| 69 | Foot dorsiflexor weakness (HP:0009027) | 2.32390161 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32343995 |
| 71 | Peripheral demyelination (HP:0011096) | 2.31793148 |
| 72 | Slender build (HP:0001533) | 2.30664712 |
| 73 | White forelock (HP:0002211) | 2.30503406 |
| 74 | Hypoplastic pelvis (HP:0008839) | 2.29255218 |
| 75 | Genu recurvatum (HP:0002816) | 2.28589355 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.27480480 |
| 77 | Recurrent abscess formation (HP:0002722) | 2.27208702 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.26648564 |
| 79 | Retinal dysplasia (HP:0007973) | 2.25622511 |
| 80 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.25274537 |
| 81 | Aplasia of the phalanges of the hand (HP:0009802) | 2.25274537 |
| 82 | Aplasia involving bones of the extremities (HP:0009825) | 2.25274537 |
| 83 | Myocardial infarction (HP:0001658) | 2.25183088 |
| 84 | Paraparesis (HP:0002385) | 2.24039504 |
| 85 | Prolonged neonatal jaundice (HP:0006579) | 2.22229634 |
| 86 | Patchy hypopigmentation of hair (HP:0011365) | 2.21802092 |
| 87 | Premature rupture of membranes (HP:0001788) | 2.21348229 |
| 88 | Wormian bones (HP:0002645) | 2.20229259 |
| 89 | Thickened helices (HP:0000391) | 2.19804896 |
| 90 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.16734309 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14979357 |
| 92 | Joint stiffness (HP:0001387) | 2.14950966 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 2.14080956 |
| 94 | Episodic fever (HP:0001954) | 2.14012644 |
| 95 | Achilles tendon contracture (HP:0001771) | 2.13864849 |
| 96 | Spondylolisthesis (HP:0003302) | 2.13426087 |
| 97 | Neuroendocrine neoplasm (HP:0100634) | 2.12092207 |
| 98 | Premature skin wrinkling (HP:0100678) | 2.11953989 |
| 99 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.10328275 |
| 100 | Rough bone trabeculation (HP:0100670) | 2.09546429 |
| 101 | Myokymia (HP:0002411) | 2.09183207 |
| 102 | Dysostosis multiplex (HP:0000943) | 2.08916403 |
| 103 | Hemorrhage of the eye (HP:0011885) | 2.08306989 |
| 104 | Absent septum pellucidum (HP:0001331) | 2.08078883 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 2.07666882 |
| 106 | Autoamputation (HP:0001218) | 2.06281435 |
| 107 | Infantile muscular hypotonia (HP:0008947) | 2.06163376 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.05877711 |
| 109 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.05863782 |
| 110 | Hypertriglyceridemia (HP:0002155) | 2.04771488 |
| 111 | Spastic tetraparesis (HP:0001285) | 2.03837302 |
| 112 | Shallow orbits (HP:0000586) | 2.03402627 |
| 113 | Abnormality of the foot musculature (HP:0001436) | 2.03239185 |
| 114 | Cellulitis (HP:0100658) | 2.03009950 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 2.02954037 |
| 116 | Amyloidosis (HP:0011034) | 2.02787028 |
| 117 | Difficulty climbing stairs (HP:0003551) | 2.02114053 |
| 118 | Ankle clonus (HP:0011448) | 2.01942412 |
| 119 | Generalized amyotrophy (HP:0003700) | 2.01279796 |
| 120 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01136111 |
| 121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01136111 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01136111 |
| 123 | Decreased motor nerve conduction velocity (HP:0003431) | 2.01078285 |
| 124 | Recurrent bacterial skin infections (HP:0005406) | 2.00918729 |
| 125 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.00405012 |
| 126 | Gastrointestinal infarctions (HP:0005244) | 1.98655367 |
| 127 | Abnormality of the pericardium (HP:0001697) | 1.98210942 |
| 128 | Upper limb amyotrophy (HP:0009129) | 1.97101403 |
| 129 | Distal upper limb amyotrophy (HP:0007149) | 1.97101403 |
| 130 | Soft skin (HP:0000977) | 1.97050648 |
| 131 | Bladder diverticulum (HP:0000015) | 1.96360780 |
| 132 | Broad metatarsal (HP:0001783) | 1.96249768 |
| 133 | Type 1 muscle fiber predominance (HP:0003803) | 1.95928513 |
| 134 | Gingivitis (HP:0000230) | 1.95720868 |
| 135 | Acute necrotizing encephalopathy (HP:0006965) | 1.94850768 |
| 136 | Erythroderma (HP:0001019) | 1.93325221 |
| 137 | Aneurysm (HP:0002617) | 1.92591960 |
| 138 | Keratoconjunctivitis (HP:0001096) | 1.91776660 |
| 139 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91131876 |
| 140 | Gowers sign (HP:0003391) | 1.90382503 |
| 141 | Disproportionate tall stature (HP:0001519) | 1.90357786 |
| 142 | Increased cerebral lipofuscin (HP:0011813) | 1.88091493 |
| 143 | Lower limb muscle weakness (HP:0007340) | 1.87308841 |
| 144 | Loss of speech (HP:0002371) | 1.86425188 |
| 145 | Split foot (HP:0001839) | 1.86314195 |
| 146 | Adrenal hypoplasia (HP:0000835) | 1.85712446 |
| 147 | Broad face (HP:0000283) | 1.84825065 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.84031191 |
| 149 | Metabolic alkalosis (HP:0200114) | 1.83670506 |
| 150 | Mitral regurgitation (HP:0001653) | 1.83205112 |
| 151 | Petechiae (HP:0000967) | 1.82810353 |
| 152 | Methylmalonic acidemia (HP:0002912) | 1.82723078 |
| 153 | Mucopolysacchariduria (HP:0008155) | 1.82592208 |
| 154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82592208 |
| 155 | Nuclear cataract (HP:0100018) | 1.82376680 |
| 156 | Eczematoid dermatitis (HP:0000976) | 1.82349005 |
| 157 | Emphysema (HP:0002097) | 1.82200120 |
| 158 | Ectopia lentis (HP:0001083) | 1.81981005 |
| 159 | Nonimmune hydrops fetalis (HP:0001790) | 1.81650681 |
| 160 | Purpura (HP:0000979) | 1.81450762 |
| 161 | Follicular hyperkeratosis (HP:0007502) | 1.79498572 |
| 162 | Anorexia (HP:0002039) | 1.78184441 |
| 163 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77798810 |
| 164 | Ulnar deviation of the wrist (HP:0003049) | 1.77363300 |
| 165 | Coronal craniosynostosis (HP:0004440) | 1.77111857 |
| 166 | Elbow flexion contracture (HP:0002987) | 1.76209962 |
| 167 | Nemaline bodies (HP:0003798) | 1.75939872 |
| 168 | Decreased lacrimation (HP:0000633) | 1.74983713 |
| 169 | Joint laxity (HP:0001388) | 1.74834928 |
| 170 | Mitral valve prolapse (HP:0001634) | 1.74134111 |
| 171 | Mediastinal lymphadenopathy (HP:0100721) | 1.74061535 |
| 172 | Easy fatigability (HP:0003388) | 1.74002664 |
| 173 | Abnormal trabecular bone morphology (HP:0100671) | 1.73708656 |
| 174 | Recurrent skin infections (HP:0001581) | 1.73166182 |
| 175 | Hammertoe (HP:0001765) | 1.72861365 |
| 176 | Polycythemia (HP:0001901) | 1.71922206 |
| 177 | Thick nail (HP:0001805) | 1.71334456 |
| 178 | Abnormality of the septum pellucidum (HP:0007375) | 1.71235791 |
| 179 | Distal sensory impairment (HP:0002936) | 1.70136938 |
| 180 | Steppage gait (HP:0003376) | 1.68912923 |
| 181 | Diminished movement (HP:0002374) | 1.68338499 |
| 182 | Difficulty running (HP:0009046) | 1.66233005 |
| 183 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.64599114 |
| 184 | Scanning speech (HP:0002168) | 1.63730638 |
| 185 | Morphological abnormality of the inner ear (HP:0011390) | 1.63518335 |
| 186 | Increased circulating renin level (HP:0000848) | 1.63245214 |
| 187 | Mitochondrial inheritance (HP:0001427) | 1.61855142 |
| 188 | Pulmonary artery stenosis (HP:0004415) | 1.61107836 |
| 189 | Hypophosphatemic rickets (HP:0004912) | 1.61014491 |
| 190 | Vacuolated lymphocytes (HP:0001922) | 1.60983624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.82260310 |
| 2 | OXSR1 | 4.09775451 |
| 3 | EPHB1 | 4.01408829 |
| 4 | ERN1 | 3.91703827 |
| 5 | IRAK3 | 3.59879858 |
| 6 | PBK | 3.47430956 |
| 7 | BCR | 3.08935252 |
| 8 | EPHA2 | 2.74224814 |
| 9 | MAP2K3 | 2.70612059 |
| 10 | MAP3K3 | 2.60220528 |
| 11 | PKN1 | 2.54323871 |
| 12 | TESK1 | 2.48162327 |
| 13 | TGFBR2 | 2.47519658 |
| 14 | LIMK1 | 2.44228142 |
| 15 | TAOK2 | 2.40627517 |
| 16 | MET | 2.38221291 |
| 17 | MAP3K11 | 2.33213323 |
| 18 | TAOK1 | 2.32841113 |
| 19 | WNK4 | 2.32470114 |
| 20 | NME2 | 2.29886930 |
| 21 | MST4 | 2.22276493 |
| 22 | SIK1 | 2.21990413 |
| 23 | RIPK1 | 2.05019136 |
| 24 | ARAF | 2.01245651 |
| 25 | CDK19 | 1.97973447 |
| 26 | PAK4 | 1.96027153 |
| 27 | WNK1 | 1.94450683 |
| 28 | MAPKAPK5 | 1.93443227 |
| 29 | PRPF4B | 1.74411192 |
| 30 | PRKD2 | 1.71995339 |
| 31 | FGR | 1.70857751 |
| 32 | EPHB2 | 1.66558549 |
| 33 | TYK2 | 1.60951437 |
| 34 | TRIB3 | 1.55273105 |
| 35 | CSNK1A1L | 1.49245001 |
| 36 | ROCK2 | 1.49236356 |
| 37 | SMG1 | 1.48087692 |
| 38 | CSNK1G3 | 1.45753216 |
| 39 | TESK2 | 1.43971400 |
| 40 | PAK6 | 1.40071329 |
| 41 | NEK6 | 1.39077477 |
| 42 | MYLK | 1.37067847 |
| 43 | NTRK1 | 1.36942417 |
| 44 | PTK2 | 1.33557572 |
| 45 | CAMK2B | 1.31774931 |
| 46 | LMTK2 | 1.31405699 |
| 47 | CAMK2D | 1.26998140 |
| 48 | MAP4K1 | 1.21169941 |
| 49 | CLK1 | 1.20964886 |
| 50 | STK10 | 1.20168211 |
| 51 | ZAP70 | 1.17960279 |
| 52 | SIK3 | 1.16757366 |
| 53 | ERBB4 | 1.16488186 |
| 54 | MAP3K1 | 1.15776968 |
| 55 | MAP3K14 | 1.14639858 |
| 56 | RIPK4 | 1.14085099 |
| 57 | FGFR2 | 1.13652365 |
| 58 | BLK | 1.13382038 |
| 59 | CSNK1G1 | 1.05807738 |
| 60 | PDGFRA | 1.04359087 |
| 61 | JAK3 | 1.03921842 |
| 62 | ICK | 1.03832038 |
| 63 | PRKG2 | 1.03578870 |
| 64 | TRPM7 | 1.01945458 |
| 65 | UHMK1 | 1.01921556 |
| 66 | CSNK1G2 | 1.01891625 |
| 67 | CDC42BPA | 0.99894480 |
| 68 | DYRK2 | 0.99730097 |
| 69 | CAMK2G | 0.99116058 |
| 70 | TTN | 0.95836754 |
| 71 | LATS2 | 0.95756078 |
| 72 | PTK6 | 0.94546022 |
| 73 | PRKCQ | 0.94087318 |
| 74 | TNIK | 0.87747517 |
| 75 | PRKD1 | 0.85855327 |
| 76 | CASK | 0.85842162 |
| 77 | GRK6 | 0.84733899 |
| 78 | STK38 | 0.84221488 |
| 79 | ABL2 | 0.83627741 |
| 80 | KSR2 | 0.83536656 |
| 81 | MAP3K12 | 0.83245799 |
| 82 | PRKCE | 0.81047280 |
| 83 | IKBKB | 0.80543787 |
| 84 | SGK223 | 0.80096086 |
| 85 | SGK494 | 0.80096086 |
| 86 | MOS | 0.79063135 |
| 87 | MAP3K13 | 0.78583783 |
| 88 | PAK3 | 0.78326414 |
| 89 | TBK1 | 0.74520146 |
| 90 | CAMK2A | 0.74349308 |
| 91 | PDPK1 | 0.72974063 |
| 92 | BMPR1B | 0.71389630 |
| 93 | HIPK2 | 0.71354733 |
| 94 | GRK5 | 0.70740041 |
| 95 | MST1R | 0.69627963 |
| 96 | BMX | 0.69474292 |
| 97 | OBSCN | 0.67526369 |
| 98 | BMPR2 | 0.67374683 |
| 99 | CDK14 | 0.67216298 |
| 100 | PIM2 | 0.66379665 |
| 101 | CSK | 0.66014295 |
| 102 | MAP3K8 | 0.60216314 |
| 103 | MAP2K2 | 0.58519430 |
| 104 | FYN | 0.58513097 |
| 105 | PAK1 | 0.58240461 |
| 106 | HCK | 0.56446786 |
| 107 | GRK7 | 0.55658250 |
| 108 | PIK3CA | 0.54677187 |
| 109 | PTK2B | 0.54122331 |
| 110 | CDK5 | 0.53718244 |
| 111 | RPS6KA5 | 0.53258849 |
| 112 | BRAF | 0.52925557 |
| 113 | DAPK3 | 0.52704552 |
| 114 | MATK | 0.52165973 |
| 115 | JAK1 | 0.51474908 |
| 116 | MARK2 | 0.51426358 |
| 117 | CDK15 | 0.50167260 |
| 118 | DDR2 | 0.49547008 |
| 119 | PHKG2 | 0.48027470 |
| 120 | PHKG1 | 0.48027470 |
| 121 | PNCK | 0.47941828 |
| 122 | ADRBK1 | 0.47828386 |
| 123 | MAP3K5 | 0.47640258 |
| 124 | GSK3A | 0.47470655 |
| 125 | TIE1 | 0.47369824 |
| 126 | IRAK4 | 0.47328190 |
| 127 | IRAK2 | 0.46929236 |
| 128 | CDK18 | 0.45427455 |
| 129 | ABL1 | 0.45195120 |
| 130 | ADRBK2 | 0.45094168 |
| 131 | TYRO3 | 0.44984277 |
| 132 | RPS6KA2 | 0.44875501 |
| 133 | LRRK2 | 0.44511735 |
| 134 | PRKG1 | 0.43213765 |
| 135 | CDK11A | 0.41266497 |
| 136 | DMPK | 0.40341439 |
| 137 | MAPKAPK2 | 0.39486536 |
| 138 | RPS6KC1 | 0.39357163 |
| 139 | RPS6KL1 | 0.39357163 |
| 140 | MAP3K6 | 0.39284506 |
| 141 | CSNK1A1 | 0.39100825 |
| 142 | TNK2 | 0.38809871 |
| 143 | JAK2 | 0.38279160 |
| 144 | CHUK | 0.37401710 |
| 145 | MAPK15 | 0.37307736 |
| 146 | EPHA4 | 0.36961224 |
| 147 | MARK1 | 0.36767049 |
| 148 | MAPK7 | 0.35960064 |
| 149 | PRKCH | 0.35749865 |
| 150 | RAF1 | 0.35668024 |
| 151 | DYRK1B | 0.34508170 |
| 152 | IRAK1 | 0.33622522 |
| 153 | INSR | 0.31388984 |
| 154 | CSNK1D | 0.29968994 |
| 155 | ILK | 0.29499985 |
| 156 | LCK | 0.28558793 |
| 157 | PDGFRB | 0.28219675 |
| 158 | FES | 0.27708577 |
| 159 | KDR | 0.27704845 |
| 160 | DYRK3 | 0.27642407 |
| 161 | IKBKE | 0.27183885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.72448362 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.54854725 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.80734229 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.89376164 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.70597916 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.65516150 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38398499 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.27192934 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19845190 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10134214 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 1.95566841 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87413753 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87136690 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86567716 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.75065842 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74403029 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66918487 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61092516 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.57379114 |
| 20 | Bladder cancer_Homo sapiens_hsa05219 | 1.56278897 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55413278 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54254839 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.52616630 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52383850 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51716109 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.51647614 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43917516 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41156740 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.40569560 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.39738534 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.37411683 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.31093338 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.30999184 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30477529 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.30102944 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.29960874 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27284223 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26892826 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.26453866 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.26386007 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.24647487 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.24099471 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.22454617 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22449375 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21282709 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.20263527 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.19898748 |
| 48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19381216 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16856995 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15307300 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15015316 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11460026 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09679393 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07824876 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06047733 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.05964706 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05010700 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02431642 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 1.01471049 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.96885333 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96656796 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96373699 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.96058921 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95483539 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95424675 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94630099 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93650427 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93100766 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91831197 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88487485 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87775099 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87443944 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86630326 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86250988 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85915559 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84773935 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82147686 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81279256 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81243987 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79037706 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78783129 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.78007919 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77076683 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76633589 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75449164 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74680136 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73826983 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73543627 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.73227243 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72469250 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72211743 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.71444484 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.70559517 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69599834 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.67724380 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66660720 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62863242 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62768636 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.62711085 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62207835 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.60791068 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60771368 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60129620 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59282777 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.59261825 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58900756 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58655808 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58226849 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57730420 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57609363 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57492265 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56978711 |
| 113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56806416 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56666751 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56603246 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56188177 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55270087 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53476354 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53243862 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52806724 |
| 121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52641034 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52111850 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51832079 |
| 124 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51662548 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51324499 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.51201516 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50550542 |
| 128 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50465529 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.50436531 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.49720049 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49371524 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47716735 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47388519 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46237386 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46216185 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.45345522 |
| 137 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45199112 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45082855 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44608749 |
| 140 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43576963 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43266433 |
| 142 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43122780 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42366287 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41801499 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40636120 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38804244 |
| 147 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37810546 |
| 148 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37579116 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35375060 |
| 150 | Hepatitis C_Homo sapiens_hsa05160 | 0.35234244 |
| 151 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34621454 |
| 152 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34180813 |
| 153 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33947833 |
| 154 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33918955 |
| 155 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33464496 |
| 156 | Long-term depression_Homo sapiens_hsa04730 | 0.32641068 |
| 157 | Morphine addiction_Homo sapiens_hsa05032 | 0.32229584 |
| 158 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30091375 |
| 159 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29162727 |
| 160 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28758768 |

